The same ligand could be "equipped" with a therapeutic radionuclide (thera) such as β-particles 177Lu or α-particles 225Ac or a diagnostic/imaging radionuclide (nostic) such as 68Ga.
Integrated diagnosis and treatment design enables the treatment process to accurately locate the tumor location and status, track the efficacy, and formulate the next treatment plan and dosage in a targeted manner.
The right molecule, The right dosage, Recovered Patient
With the help of low-energy radionuclides, physicians can apply imaging to detect tumor expression in patients, observe and measure the tumor progression in vivo.
Targeted radiopharmaceuticals deliver radioactive warheads directly to tumor cells to destroy target-expressing cancer cells. Targeted radiation therapy is a promising approach to treat metastatic cancer.
